Autolus Therapeutics Plc (AUTL)
2.305
-0.04
(-1.91%)
USD |
NASDAQ |
Sep 01, 16:00
2.31
0.00 (0.00%)
After-Hours: 17:26
Autolus Therapeutics Total Long Term Debt (Quarterly) : 362.02M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 362.02M |
| March 31, 2026 | 366.06M |
| December 31, 2025 | 347.02M |
| September 30, 2025 | 320.35M |
| June 30, 2025 | 311.89M |
| March 31, 2025 | 308.17M |
| December 31, 2024 | 294.23M |
| September 30, 2024 | 297.60M |
| June 30, 2024 | 284.46M |
| March 31, 2024 | 275.01M |
| December 31, 2023 | 218.81M |
| September 30, 2023 | 46.97M |
| June 30, 2023 | 44.71M |
| March 31, 2023 | 22.50M |
| December 31, 2022 | 145.12M |
| Date | Value |
|---|---|
| September 30, 2022 | 11.31M |
| June 30, 2022 | 13.21M |
| March 31, 2022 | 15.08M |
| December 31, 2021 | 16.54M |
| September 30, 2021 | 17.34M |
| June 30, 2021 | 18.79M |
| March 31, 2021 | 19.58M |
| December 31, 2020 | 50.57M |
| September 30, 2020 | 49.46M |
| June 30, 2020 | 24.33M |
| March 31, 2020 | 24.14M |
| December 31, 2019 | 23.71M |
| September 30, 2019 | 24.41M |
| June 30, 2019 | 25.50M |
| March 31, 2019 | 26.45M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Bicycle Therapeutics Plc | 14.44M |
| Biodexa Pharmaceuticals Plc | 0.00 |
| argenx SE | 0.00 |
| NuCana Plc | 0.892M |
| Mereo BioPharma Group Plc | 0.00 |